These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9724373)

  • 41. PET imaging in breast cancer.
    Bombardieri E; Crippa F
    Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results.
    Sugawara Y; Braun DK; Kison PV; Russo JE; Zasadny KR; Wahl RL
    Eur J Nucl Med; 1998 Sep; 25(9):1238-43. PubMed ID: 9724371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
    Hoegerle S; Altehoefer C; Ghanem N; Brink I; Moser E; Nitzsche E
    Eur J Nucl Med; 2001 Jan; 28(1):64-71. PubMed ID: 11202454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [18F]FLT PET for diagnosis and staging of thoracic tumours.
    Dittmann H; Dohmen BM; Paulsen F; Eichhorn K; Eschmann SM; Horger M; Wehrmann M; Machulla HJ; Bares R
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1407-12. PubMed ID: 12898201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo ¹⁸F-FDG tumour uptake measurements in small animals using Cerenkov radiation.
    Boschi F; Calderan L; D'Ambrosio D; Marengo M; Fenzi A; Calandrino R; Sbarbati A; Spinelli AE
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):120-7. PubMed ID: 20882278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
    Scheidhauer K; Scharl A; Pietrzyk U; Wagner R; Göhring UJ; Schomäcker K; Schicha H
    Eur J Nucl Med; 1996 Jun; 23(6):618-23. PubMed ID: 8662094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible?
    Schulte M; Brecht-Krauss D; Heymer B; Guhlmann A; Hartwig E; Sarkar MR; Diederichs CG; Schultheiss M; Kotzerke J; Reske SN
    Eur J Nucl Med; 1999 Jun; 26(6):599-605. PubMed ID: 10369945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.
    Lai AYT; Perucho JAU; Xu X; Hui ES; Lee EYP
    BMC Cancer; 2017 Dec; 17(1):825. PubMed ID: 29207964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of hemangioma by positron emission tomography: role in a multimodality approach.
    Hatayama K; Watanabe H; Ahmed AR; Yanagawa T; Shinozaki T; Oriuchi N; Aoki J; Takeuchi K; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(1):70-7. PubMed ID: 12544246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
    De Wit M; Raabe A; Seegers B; Buchert R; Beck-Bornholdt HP; Alberti W; Hossfeld DK
    Int J Radiat Biol; 2004 Jul; 80(7):529-39. PubMed ID: 15360091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
    Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
    Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influx rate of
    Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer.
    Brandt-Mainz K; Müller SP; Görges R; Saller B; Bockisch A
    Eur J Nucl Med; 2000 May; 27(5):490-6. PubMed ID: 10853802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole-body [18F]FDG PET in the management of metastatic brain tumours.
    Kim DG; Kim CY; Paek SH; Lee DS; Chung JK; Jung HW; Cho BK
    Acta Neurochir (Wien); 1998; 140(7):665-73; discussion 673-4. PubMed ID: 9781280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.
    von Forstner C; Egberts JH; Ammerpohl O; Niedzielska D; Buchert R; Mikecz P; Schumacher U; Peldschus K; Adam G; Pilarsky C; Grutzmann R; Kalthoff H; Henze E; Brenner W
    J Nucl Med; 2008 Aug; 49(8):1362-70. PubMed ID: 18632830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET imaging of primary mediastinal tumours.
    Kubota K; Yamada S; Kondo T; Yamada K; Fukuda H; Fujiwara T; Ito M; Ido T
    Br J Cancer; 1996 Apr; 73(7):882-6. PubMed ID: 8611400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET.
    Ambrosini V; Nanni C; Pettinato C; Fini M; D'Errico A; Trepidi S; Spinelli A; Al-Nahhas A; Rubello D; Zompatori M; Fabbri M; Franchi R; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):647-52. PubMed ID: 17625387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.